These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 26188133)

  • 1. Novel CCR3 Antagonists Are Effective Mono- and Combination Inhibitors of Choroidal Neovascular Growth and Vascular Permeability.
    Nagai N; Ju M; Izumi-Nagai K; Robbie SJ; Bainbridge JW; Gale DC; Pierre E; Krauss AH; Adamson P; Shima DT; Ng YS
    Am J Pathol; 2015 Sep; 185(9):2534-49. PubMed ID: 26188133
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retinal Inhibition of CCR3 Induces Retinal Cell Death in a Murine Model of Choroidal Neovascularization.
    Wang H; Han X; Gambhir D; Becker S; Kunz E; Liu AJ; Hartnett ME
    PLoS One; 2016; 11(6):e0157748. PubMed ID: 27309355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CCR3 is a target for age-related macular degeneration diagnosis and therapy.
    Takeda A; Baffi JZ; Kleinman ME; Cho WG; Nozaki M; Yamada K; Kaneko H; Albuquerque RJ; Dridi S; Saito K; Raisler BJ; Budd SJ; Geisen P; Munitz A; Ambati BK; Green MG; Ishibashi T; Wright JD; Humbles AA; Gerard CJ; Ogura Y; Pan Y; Smith JR; Grisanti S; Hartnett ME; Rothenberg ME; Ambati J
    Nature; 2009 Jul; 460(7252):225-30. PubMed ID: 19525930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Choroidal neovascularization reduced by targeted drug delivery with cationic liposome-encapsulated paclitaxel or targeted photodynamic therapy with verteporfin encapsulated in cationic liposomes.
    Gross N; Ranjbar M; Evers C; Hua J; Martin G; Schulze B; Michaelis U; Hansen LL; Agostini HT
    Mol Vis; 2013; 19():54-61. PubMed ID: 23335851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppression of laser-induced choroidal neovascularization by a CCR3 antagonist.
    Mizutani T; Ashikari M; Tokoro M; Nozaki M; Ogura Y
    Invest Ophthalmol Vis Sci; 2013 Feb; 54(2):1564-72. PubMed ID: 23404125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic Effects of PPARα Agonist on Ocular Neovascularization in Models Recapitulating Neovascular Age-Related Macular Degeneration.
    Qiu F; Matlock G; Chen Q; Zhou K; Du Y; Wang X; Ma JX
    Invest Ophthalmol Vis Sci; 2017 Oct; 58(12):5065-5075. PubMed ID: 28980001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of ocular angiogenesis by Notch signaling: implications in neovascular age-related macular degeneration.
    Ahmad I; Balasubramanian S; Del Debbio CB; Parameswaran S; Katz AR; Toris C; Fariss RN
    Invest Ophthalmol Vis Sci; 2011 May; 52(6):2868-78. PubMed ID: 21228388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CCR3 and choroidal neovascularization.
    Li Y; Huang D; Xia X; Wang Z; Luo L; Wen R
    PLoS One; 2011 Feb; 6(2):e17106. PubMed ID: 21358803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel CCR3-targeted cyclic peptides as potential therapeutic agents for age-related macular degeneration via inhibiting angiogenesis and reducing retinal photoreceptor damage.
    Li Y; Guo S; Wu X; Wan J; Guan Y; Luo C; Chen Q; Jiang H; Lin H; Qian H; Shi W; Fan W
    Bioorg Chem; 2024 Jun; 147():107405. PubMed ID: 38696843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in Fundus Autofluorescence after Anti-vascular Endothelial Growth Factor According to the Type of Choroidal Neovascularization in Age-related Macular Degeneration.
    Lee JY; Chung H; Kim HC
    Korean J Ophthalmol; 2016 Feb; 30(1):17-24. PubMed ID: 26865799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Repurposing bortezomib for choroidal neovascularization treatment via antagonizing VEGF-A and PDGF-D mediated signaling.
    Liu Y; Feng M; Cai J; Li S; Dai X; Shan G; Wu S
    Exp Eye Res; 2021 Mar; 204():108446. PubMed ID: 33476605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes by Baseline Choroidal Neovascularization Features in Age-Related Macular Degeneration: A Post Hoc Analysis of the VIEW Studies.
    Steinle NC; Du W; Gibson A; Saroj N
    Ophthalmol Retina; 2021 Feb; 5(2):141-150. PubMed ID: 32652314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apatinib, an Inhibitor of Vascular Endothelial Growth Factor Receptor 2, Suppresses Pathologic Ocular Neovascularization in Mice.
    Kim KL; Suh W
    Invest Ophthalmol Vis Sci; 2017 Jul; 58(9):3592-3599. PubMed ID: 28715845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of nicotine on anti-vascular endothelial growth factor therapy in a mouse model of neovascular age-related macular degeneration.
    Davis SJ; Lyzogubov VV; Tytarenko RG; Safar AN; Bora NS; Bora PS
    Retina; 2012 Jun; 32(6):1171-80. PubMed ID: 22088983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. VEGFR2 Trafficking by KIF13B Is a Novel Therapeutic Target for Wet Age-Related Macular Degeneration.
    Waters SB; Zhou C; Nguyen T; Zelkha R; Lee H; Kazlauskas A; Rosenblatt MI; Malik AB; Yamada KH
    Invest Ophthalmol Vis Sci; 2021 Feb; 62(2):5. PubMed ID: 33533881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic deficiency and pharmacological modulation of RORα regulate laser-induced choroidal neovascularization.
    Liu CH; Yemanyi F; Bora K; Kushwah N; Blomfield AK; Kamenecka TM; SanGiovanni JP; Sun Y; Solt LA; Chen J
    Aging (Albany NY); 2023 Jan; 15(1):37-52. PubMed ID: 36626253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of Hypoxia-Inducible Factor-1α and Vascular Endothelial Growth Factor by Chrysin in a Rat Model of Choroidal Neovascularization.
    Song JH; Moon KY; Lee SC; Kim SS
    Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32325771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brivanib, a multitargeted small-molecule tyrosine kinase inhibitor, suppresses laser-induced CNV in a mouse model of neovascular AMD.
    Li L; Zhu M; Wu W; Qin B; Gu J; Tu Y; Chen J; Liu D; Shi Y; Liu X; Sang A; Ding D
    J Cell Physiol; 2020 Feb; 235(2):1259-1273. PubMed ID: 31270802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. VEGF receptor blockade markedly reduces retinal microglia/macrophage infiltration into laser-induced CNV.
    Huang H; Parlier R; Shen JK; Lutty GA; Vinores SA
    PLoS One; 2013; 8(8):e71808. PubMed ID: 23977149
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic human CR2-targeted complement alternative pathway inhibitor ameliorates mouse laser-induced choroidal neovascularization.
    Rohrer B; Coughlin B; Bandyopadhyay M; Holers VM
    J Ocul Pharmacol Ther; 2012 Aug; 28(4):402-9. PubMed ID: 22309197
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.